A narrative review evaluating the safety and efficacy of e-cigarettes as a newly marketed smoking cessation tool

SAGE Open Medicine

Volumn 7, Issue , 2019, Pages

  Worku, Dominic ^a   Worku, Elliott ^b  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

E cigarettes; electronic nicotine delivery system; safety; smoking cessation; vaping

Indexed keywords

CADMIUM; CARBON MONOXIDE; CINNAMALDEHYDE; COTININE; COUMARIN; MALTOL; NICOTINE; NITRIC OXIDE;

APOPTOSIS; ASTHMA; AWARENESS; BIOFILM; CAENORHABDITIS ELEGANS; CARDIOVASCULAR DISEASE; CELL VIABILITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYTOTOXICITY; DRUG EFFICACY; DRUG SAFETY; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENE EXPRESSION; HEADACHE; HEART RATE; HEMODYNAMICS; HUMAN; OXIDATIVE STRESS; PASSIVE SMOKING; PEER REVIEW; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SMOKING CESSATION; VAPING;

EID: 85077248247     PISSN: None     EISSN: 20503121     Source Type: Journal    
DOI: 10.1177/2050312119871405     Document Type: Review

References (58)

1. Alshishtawy MM., Tobacco smoking. Sultan Qaboos Univ Med J 2013; 13(3): 341–344.
2. Waldum HL, Nilsen OG, Nilsen T. Long-term effects of inhaled nicotine. Life Sci 1996; 58(16): 1339–1346.
3. Garcia-Arcos I, Geraghty P, Baumlin N. Chronic electronic cigarette exposure in mice induces features of COPD in a nicotine-dependent manner. Thorax 2016; 71(12): 1119–1129.
4. Dwyer JB, McQuown SC, Leslie FM., The dynamic effects of nicotine on the developing brain. Pharmacol Ther 2009; 122(2): 125–139.
5. Franks AS, Sando K, McBane S., Do electronic cigarettes have a role in tobacco cessation? Pharmacotherapy 2018; 38(5): 555–568.
6. Rom O, Pecorelli A, Giuseppe V. Are E-cigarettes a safe and good alternative to cigarette smoking. Ann N Y Acad Sci 2015; 1340: 65–74.
7. Manigrasso M, Vitali M, Protano C. Ultrafine particles in domestic environments: regional doses deposited in the human respiratory system. Environ Int 2018; 118: 134–145.
8. Protano C, Manigrasso M, Avino P. Second-hand smoke generated by combustion and electronic smoking devices used in real scenarios: ultrafine particle pollution and age-related dose assessment. Environ Int 2017; 107: 190–195.
9. Hitchman SC, Brose LS, Brown J. Associations between e-cigarette type, frequency of use, and quitting smoking: findings from a longitudinal online panel survey in Great Britain. Nicotine Tob Res 2015; 17(10): 1187–1194.
10. Rahman MA, Hann N, Wilson A. E-cigarettes and smoking cessation: evidence from a systematic review and meta-analysis. PLoS ONE 2015; 10(3): e0122544.
11. Kalkhoran S, Glantz SA., E-cigarettes and smoking cessation in real-world and clinical settings: a systematic review and meta-analysis. Lancet Respir Med 2016; 4(2): 116–128.
12. Mead EL, Duffy V, Oncken C. E-cigarette palatability in smokers as a function of flavorings, nicotine content and propylthiouracil (PROP) taster phenotype. Addict Behav 2019; 91: 37–44.
13. Royal College of Physicians. Promote e-cigarettes widely as substitute for smoking says new RCP report. Royal College of Physicians, 2016, https://www.rcplondon.ac.uk/news/promote-e-cigarettes-widely-substitute-smoking-says-new-rcp-report (accessed 2 October 2018).
14. Ebbert JO, Agunwamba AA, Rutten LJ., Counseling patients on the use of electronic cigarettes. Mayo Clin Proc 2015; 90(1): 128–134.
15. Biyani S, Derkay CS., E-cigarettes: considerations for the otolaryngologist. Int J Pediatr Otorhinolaryngol 2015; 79: 1180–1183.
16. Orellana-Barrios MA, Payne D, Mulkey Z. Electronic cigarettes – a narrative review for clinicians. Am J Med 2015; 128(7): 674–681.
17. Chaffee BW., Electronic cigarettes: trends, health effects and advising patients amid uncertainty. J Calif Dent Assoc 2019; 47(2): 85–92.
18. England LJ, Bunnell RE, Pechacek TF. Nicotine and the developing human: a neglected element in the electronic cigarette debate. Am J Prev Med 2015; 49(2): 286–293.
19. Stone E, Marshall H., Electronic cigarettes in physician practice: a complex debate. Intern Med J 2019; 49(4): 438–445.
20. Kaisar MA, Prasad S, Liles T. A decade of e-cigarettes: limited research & unresolved safety concerns. Toxicology 2016; 365: 67–75.
21. Callahan-Lyon P., Electronic cigarettes: human health effects. Tob Control 2014; 23(Suppl. 2): ii36–ii40.
22. Offermann FJ., Chemical emissions from e-cigarettes: direct and indirect (passive) exposures. Build Environ 2015; 93: 101–105.
23. Protano C, Avino P, Manigrasso M. Environmental electronic vape exposure from four different generations of electronic cigarettes: airborne particulate matter levels. Int J Environ Res Public Health 2018; 15: 2172.
24. Jablow LM, Sexton RJ., Spontaneous electronic cigarette explosion: a case report. Am J Med Cas Rep 2015; 3(4): 93–94.
25. Arnaout A, Khashaba H, Dobbs T. The Southwest UK Burns Network (SWUK) experience of electronic cigarette explosions and review of literature. Burns 2017; 43: e1–e6.
26. Kaur G, Pinkston R, Mclemore B. Immunological and toxicological risk assessment of e-cigarettes. Eur Respir Rev 2018; 27(147): 170119.
27. Lerner CA, Sundar IK, Rahman I., Vapors produced by electronic cigarettes and e-juices with flavorings induce toxicity, oxidative stress, and inflammatory response in lung epithelial cells and in mouse lung. PLoS ONE 2015; 10: e0116732.
28. Schober W, Fembacher L, Frenzen A. Passive exposure to pollutants from conventional cigarettes and new electronic smoking devices (IQOS, e-cigarette) in passenger cars. Int J Hyg Environ Health 2019; 222(3): 486–493.
29. Shields PG, Berman M, Brasky TM. A review of pulmonary toxicity of electronic cigarettes in the context of smoking: a focus on inflammation. Cancer Epidemiol Biomarkers Prev 2017; 26(8): 1175–1191.
30. Shabab L, Goniewicz ML, Blount BC. Nicotine, carcinogen, and toxin exposure in long-term e-cigarette and nicotine replacement therapy users: a cross-sectional study. Ann Intern Med 2017; 166(6): 390–400.
31. Fearon IM, Eldridge AC, Gale N. Nicotine pharmacokinetics of electronic cigarettes: a review of the literature. Regul Toxicol Pharmacol 2018; 100: 25–34.
32. Li Z, Nair SK., Quorum sensing: how bacteria can coordinate activity and synchronize their response to external signals. Protein Sci 2012; 21(10): 1403–1417.
33. Campagna D, Cibella F, Caponnetto P. Changes in breathomics from a 1-year randomized smoking cessation trial of electronic cigarettes. Eur J Clin Invest 2016; 46: 689–706.
34. Polosa R, Cibella F, Caponnetto P. Health impact of E-cigarettes: a prospective 3.5-year study of regular daily users who have never smoked. Sci Rep 2017; 7: 13825.
35. Osei AD, Mirbolouk M, Orimoloye OA. Association between e-cigarette use and cardiovascular disease among never and current combustible-cigarette smokers. Am J Med. Epub ahead of print 8 March 2019. DOI: 10.1016/j.amjmed.2019.02.016.
36. Gerloff J, Sundar IK, Freter R. Inflammatory response and barrier dysfunction by different e-cigarette flavoring chemicals identified by gas chromatography-mass spectrometry in e-liquids and e-vapors on human lung epithelial cells and fibroblasts. Appl Vitro Toxicol 2017; 3(1): 28–40.
37. Tierney PA, Karpinski CD, Brown JE. Flavour chemicals in electronic cigarette fluids. Tob Control 2016; 25(e1): e10–e15.
38. Czekala L, Simms L, Stevenson M. High content screening in NHBE cells shows significantly reduced biological activity of flavoured e-liquids, when compared to cigarette smoke condensate. Toxicol Vitro 2019; 58: 86–96.
39. Putzhammer R, Doppler C, Jakschitz T. Vapours of US and EU market leader electronic cigarette brands and liquids are cytotoxic for human vascular endothelial cells. PLoS ONE 2016; 11(6): e0157337.
40. England LJ, Anderson BL, Tong VTK. Screening practices and attitudes of obstetricians-gynecologists toward new and emerging tobacco products. Am J Obstet Gynaecol 2014; 211: 695.e1–695.e7.
41. Suter MA, Mastrobattista J, Sachs M. Is there evidence for potential harm of electronic cigarette use in pregnancy. Birth Defects Res A Clin Mol Teratol 2015; 103(3): 186–195.
42. Rehan V, Liu J, Naeem E. Perinatal nicotine exposure induces asthma in second generation offspring. BMC Med 2012; 10: 129.
43. Palpant NJ, Hofsteen P, Pabon L. Cardiac development in zebrafish and human embryonic stem cells is inhibited by exposure to tobacco cigarettes and e-cigarettes. PLoS ONE 2015; 10(5): e0126259.
44. Panitz D, Swamy H, Nehrke KA. C. elegans model of electronic cigarette use: physiological effects of e-liquids in nematodes. BMC Pharmacol Toxicol 2015; 16: 32.
45. Kennedy AE, Kandalam S, Olivares-Navarrete R. E-cigarette aerosol exposure can cause craniofacial defects in Xenopus laevis embryos and mammalian neural crest cells. PLoS ONE 2017; 12(9): e0185729.
46. Kollath-Cattano C, Dorman T, AlbanoA W, Jr. E-cigarettes and the clinical encounter: physician perspectives on e-cigarette safety, effectiveness, and patient educational needs. J Eval Clin Pract. Epub ahead of print 19 February 2019. DOI: 10.1111/jep.13111.
47. Corkill J, Faber S, Irshad I. UK doctors current perceptions of E-cigarettes (vaping). Thorax 2018; 73(Suppl. 4): A32.
48. NHS. SmokeFree: NHS: expert support, https://www.nhs.uk/smokefree/help-and-advice (accessed 14 May 2018).
49. Hartmann-Boyce J, McRobbie H, Bullen C. Electronic cigarettes for smoking cessation. Cochrane Db Syst Rev 2016; 2016: CD010216.
50. Hajek P, Phillips-Waller A, Przulj D. A randomized trial of e-cigarettes versus nicotine-replacement therapy. N Engl J Med 2019; 380: 629–637.
51. Kroger CB, Ofner S, Piontek D., Use of E-cigarettes as an additional tool in a smoking cessation group intervention: results after 12 months. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2018; 61: 32–39.
52. Brown J, Beard E, Kotz D. Real-world effectiveness of e-cigarettes when used to aid smoking cessation: a cross-sectional population study. Addiction 2014; 109(9): 1531–1540.
53. Barbeau AM, Burda J, Siegel M., Perceived efficacy of e-cigarettes versus nicotine replacement therapy among successful e-cigarette users: a qualitative approach. Addict Sci Clin Pract 2013; 8: 5.
54. Peppone LJ, Mustian KM, Morrow GR. The effect of cigarette smoking on cancer treatment-related side effects. Oncologist 2011; 16(12): 1784–1792.
55. Borderud SP, Li Y, Burkhalter JE. Electronic cigarette use among patients with cancer: characteristics of electronic cigarette users and their smoking cessation outcomes. Cancer 2014; 120(22): 3527–3535.
56. Rigotti NA, Chang Y, Tindle HA. Association of E-cigarette use with smoking cessation among smokers who plan to quit after a hospitalization: a prospective study. Ann Intern Med 2018; 168(9): 613–620.
57. Barrington-Trimis JL, Urman R, Berhane K. E-cigarettes and future cigarette use. Pediatrics 2016; 138(1): e20160379.
58. Hallingberg B, Maynard OM, Bauld L. Have E-cigarettes renormalised or displaced youth smoking? Results of a segmented regression analysis of repeated cross sectional survey data in England, Scotland and Wales. Tob Control. Epub ahead of print 8 March 2019. DOI: 10.1136/tobaccocontrol-2018-054584.